• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

New Staging System Proposed for HPV-Related Oropharyngeal Cancer

August 18, 2016

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Currently, all oropharyngeal cancers (OPC), whether HPV-positive or HPV-negative, use the 7th edition Union for International Cancer Control/American Joint Committee on Cancer (UICC/AJCC) TNM staging system. Patients with HPV-positive cancers have higher overall survival than their HPV-negative counterparts by a wide margin, however. This disparity in overall survival affects outcomes research and interferes with clinical decision making because prognosis is not reflected by the current system.
Researchers of a report published earlier this year propose a new staging system for human papillomavirus (HPV)-related OPC (Lancet. 2016;17:440-451). The authors developed the system based on findings from the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S) study.
The researchers explored alternative staging criteria based on current TNM staging, which is based on the tumor (T category), whether or not the cancer has reached nearby lymph nodes (N category), and metastasis (M category).
The investigators showed that applying the current TNM staging criteria to patients with HPV-positive cancers did not take into account the uniqueness of this particular cancer. They did not find differences in survival between stage groups, and the distribution of patients was unbalanced; the current criteria classified the majority of patients as having stage IV disease. Thus, they sought to develop a revised staging system that would separate patients with HPV-related OPC.
“Staging is a critical component of designing treatment plans and for predicting and helping patients understand their prognosis,” said Erich M. Sturgis, MD, professor in the department of head and neck surgery at The University of Texas MD Anderson Cancer Center in Houston and co-author of the study. “Patients with HPV-positive OPC tend to present with more advanced disease, but also typically have better survival rates than those with HPV-unrelated OPC. These cancers are markedly different and require different staging criteria.”

You Might Also Like

  • Tests Emerging as Standards for Diagnosing HPV-Positive Oropharyngeal Cancer
  • HPV Status an Independent Prognostic Factor for Oropharyngeal Cancer Survival
  • HPV Related to Rise in Head and Neck Cancers
  • Further Research Needed for HPV-Related Cancer Surveillance
Explore This Issue
August 2016

The Study
The ICON-S study, an international effort to develop a pretreatment TNM clinical staging classification specific to HPV-positive OPC, studied 1,907 patients from seven institutions in Europe and North America, including one training center (n = 661) and six validation centers (n = 1,246). Investigators included patients with newly diagnosed non-metastatic OPC undergoing either primary surgery or primary radiotherapy with or without chemotherapy and determined HPV status with p16 staining or in situ hybridization.
Among all patients, according to the UICC/AJCC staging system, the five-year overall survival rate was similar among those with TNM stage I (88%), II (82%), III (84%), and IVA disease (81%) but significantly lower in those with stage IVB disease (60%). For N stage, five-year overall survival was similar for N0 (80%), N1–N2a (87%), and N2b (83%) but was significantly lower for N3 disease (59%). No difference in five-year survival was found between T4a and T4b disease (58% versus 57%).

Pages: 1 2 | Single Page

Filed Under: Features, Head and Neck, Practice Focus Tagged With: cancer, HPV, oropharyngeal cancer, stagingIssue: August 2016

You Might Also Like:

  • Tests Emerging as Standards for Diagnosing HPV-Positive Oropharyngeal Cancer
  • HPV Status an Independent Prognostic Factor for Oropharyngeal Cancer Survival
  • HPV Related to Rise in Head and Neck Cancers
  • Further Research Needed for HPV-Related Cancer Surveillance

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • Excitement Around Gene Therapy for Hearing Restoration

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939